A Safety and Efficacy Trial of Stannsoporfin in Neonates With Hyperbilirubinemia

Clinical trial NCT00850993 · TERMINATED

Trial details

NCT number: NCT00850993
Sponsor: InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hyperbilirubinemia, Neonatal

Start date: 2008-08-01
Primary completion: 2011-06-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.